Craft

Maravai LifeSciences

Stock Price

$7.1

2024-10-29

Market Capitalization

$1.8 B

2024-10-29

Revenue

$185.7 M

FY, 2025

Maravai LifeSciences Summary

Company Summary

Overview
Maravai LifeSciences is a life sciences company providing products to enable the development of drug therapies, diagnostics, vaccines, and support research on human diseases. Its products address the key phases of biopharmaceutical development and include complex nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. Maravai LifeSciences serves biopharma, vaccine, diagnostics, and cell and gene therapy companies.
Type
Public
Status
Active
Founded
2014
HQ
San Diego, CA, US | view all locations
Website
https://www.maravai.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Carl Hull, Chief Executive Officer, Chairman of the Board and Founder

Operating MetricsView all

Customers

5K

Q3, 2020

CleanCap Customers

100

Q3, 2020

Products

7

Q3, 2020

LocationsView all

6 locations detected

  • San Diego, CA HQ

    United States

    10770 Wateridge Cir #200

  • Chicago, IL

    United States

    300 N LaSalle Dr

  • NY

    United States

    6201 15th Ave, Brooklyn

  • Burlingame, CA

    United States

  • Southport, NC

    United States

  • Sterling, VA

    United States

Maravai LifeSciences Financials

Summary Financials

Revenue (Q1, 2026)
$65.8M
Gross profit (Q1, 2026)
$33.7M
Net income (Q1, 2026)
($6.4M)
Cash (Q1, 2026)
$165.9M
EBIT (Q1, 2026)
($2.2M)
Enterprise value
$1.9B

Footer menu